Blood-based Test, Videssa Breast, Seen to Aid in Detecting Cancer Regardless of Breast Density

Blood-based Test, Videssa Breast, Seen to Aid in Detecting Cancer Regardless of Breast Density
Provista Diagnostics recently reported promising data on its blood-based diagnostic test, Videssa Breast, to aid in the detection of breast cancer, even in women with dense breasts. The results were presented at the recent 15th Human Proteome Organization World Congress, held in Taipei, Taiwan, by the company's president and chief executive officer, David Reese. “We are excited for the opportunity to present on Provista’s serum-based combinatorial proteomic biomarker assay, called Videssa Breast,” said Reese in a recent press release. “Particularly because the test results are unaffected by dense breast tissue, this assay is an important advancement in proteomic technologies for addressing the many challenges clinicians face in detecting breast cancer in their patients.” Women with dense breasts, or those with abnormal or difficult-to-interpret mammography results, can face difficult decisions on whether to proceed with additional imaging or biopsy. Provista's data suggests that Videssa Breast can help by accurately detecting the presence of breast cancer with a simple blood draw. The test detects breast cancer, rather than assessing a patient's risk for developing cancer, by identifying breast cancer biomarkers. The combination of this proteomic approach with traditional imaging adds biochemical evidence, allowi
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.